Table 2. Correlation between various parameters.
ρ* p* |
log MAR VA | Axial length | IOP | MD | v C/D ratio | cpRNFLT | mIRT | CRAE | CRVE | ACF | CECD | Medications Used |
---|---|---|---|---|---|---|---|---|---|---|---|---|
log MAR VA | 0.0258 | 0.0494 | -0.3514 | 0.2248 | -0.1332 | 0.0771 | -0.3275 | -0.3377 | 0.4793 | 0.0396 | 0.068 | |
Axial length | 0.8446 | 0.1922 | -0.1287 | 0.0708 | -0.2596 | -0.0986 | -0.0700 | -0.0358 | 0.0607 | -0.0401 | 0.1769 | |
IOP | 0.7079 | 0.1412 | -0.4737 | 0.4829 | -0.5617 | -0.2906 | -0.4314 | -0.405 | 0.2407 | -0.2441 | 0.3903 | |
MD | 0.0059 | 0.327 | 0.0001 | -0.6585 | 0.7449 | -0.1722 | 0.4990 | 0.1928 | -0.4711 | .3165 | -0.5299 | |
v C/D ratio | 0.0842 | 0.591 | < .0001 | < .0001 | -0.7543 | 0.2192 | -0.4792 | -0.1929 | 0.3038 | -0.2624 | 0.3703 | |
cpRNFLT | 0.3102 | 0.0452 | < .0001 | < .0001 | < .0001 | 0.0275 | 0.4564 | 0.3684 | -0.32 | 0.2807 | -0.4918 | |
mIRT | 0.558 | 0.4533 | 0.0243 | 0.1883 | 0.0924 | 0.8349 | 0.3826 | 0.2358 | 0.1872 | -0.2045 | 0.1572 | |
CRAE | 0.0106 | 0.5953 | 0.0006 | < .0001 | 0.0001 | 0.0002 | 0.0026 | 0.4469 | -0.3961 | 0.1378 | -0.3898 | |
CRVE | 0.0083 | 0.7857 | 0.7584 | 0.1399 | 0.1397 | 0.0038 | 0.0697 | 0.0003 | -0.5175 | -0.1440 | -0.2315 | |
ACF | 0.0001 | 0.6451 | 0.0639 | 0.0001 | 0.0183 | 0.0127 | 0.152 | 0.0017 | < .0001 | -0.0658 | 0.4106 | |
CECD | 0.7636 | 0.7611 | 0.0601 | 0.0137 | 0.0428 | 0.0298 | 0.1171 | 0.2937 | 0.2722 | 0.6174 | -0.0844 | |
Medications Used | 0.6058 | 0.1764 | 0.0021 | < .0001 | 0.0036 | < .0001 | 0.2302 | 0.0021 | 0.0751 | 0.0011 | 0.5215 |
PE, pseudoexfoliation material; log MAR VA, logarithm of the minimum angle of resolution visual acuity; IOP, intraocular pressure; MD, visual field mean deviation values; vC/D ratio, vertical cup-to-disc ratio; cpRNFL, circumpapillary retinal nerve fiber layer; mIR, macular inner retinal; CRAE, central retinal arteriolar equivalent; CRVE, central retinal venular equivalent; ACF, anterior chamber flare; CECD, corneal endothelial cell density; Medications, number of antiglaucoma medications use.
*Correlation coefficient (ρ) and P values for each pair of parameters are calculated using Spearman’s correlation test.